By Liz Hoffman ( June 8, 2012, 12:05 PM EDT) -- GlaxoSmithKline PLC on Friday extended its $2.6 billion takeover offer for Human Genome Sciences Inc. through the end of June, after investors in the genetic-drug biotechnology company tendered less than 1 percent of outstanding shares....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.